Medinet Co (TSE:2370) EBIT: 円-1,284.3 Mil (TTM As of Mar. 2026)


TSE:2370 Medinet Co Ltd TSE:2370
41 GF Score
Price 円25.00
GF Value 円41.74
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Medinet Co EBIT?

Medinet Co TSE:2370 41 EBIT is 円-1,284.3 Mil as of Mar. 2026. GuruFocus rates TSE:2370 with a GF Score™ of 41/100 and a GF Value™ of 円41.74 (Possible Value Trap). The stock has 6 warning signs investors should review.

Medinet Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was 円-291.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,284.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medinet Co's annualized ROC % for the quarter that ended in Mar. 2026 was -101.37%. Medinet Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -204.33%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medinet Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -33.77%.

Medinet Co  (TSE:2370) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medinet Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-1034.94 * ( 1 - 0% )/( (1054.616 + 987.378)/ 2 )
=-1034.94/1020.997
=-101.37 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3954.653 - 48.659 - ( 2851.378 - max(0, 287.016 - 3326.392+2851.378))
=1054.616

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3987.459 - 71.935 - ( 2928.146 - max(0, 238.761 - 3439.811+2928.146))
=987.378

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Medinet Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1166.632/( ( (347.341 + max(187.998, 0)) + (333.664 + max(272.904, 0)) )/ 2 )
=-1166.632/( ( 535.339 + 606.568 )/ 2 )
=-1166.632/570.9535
=-204.33 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(258.911 + 73.565 + 142.538) - (48.659 + 0 + 238.357)
=187.998

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(335.678 + 81.584 + 94.403) - (71.935 + 0 + 166.826)
=272.904

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medinet Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-1284.252/3802.834
=-33.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinet Co EBIT Related Terms

Medinet Co EBIT Historical Data

* Premium members only.

The historical data trend for Medinet Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinet Co EBIT Chart

Medinet Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -837.74 -1,248.69 -1,433.74 -1,273.15 -1,357.92

Medinet Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -405.10 -249.27 -338.22 -291.66

TSE:2370 vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Medinet Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medinet Co EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medinet Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medinet Co's EV-to-EBIT falls into.


TSE:2370
41GF Score
Medinet Co Ltd TSE:2370
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinet Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,284.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円-1,284.3 Mil mean?
Medinet Co (TSE:2370) has a EBIT of 円-1,284.3 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medinet Co.
Is Medinet Co's EBIT too high?
Medinet Co's current EBIT is 円-1,284.3 Mil. Overall, Medinet Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's EBIT compare to VRTX and REGN?
Medinet Co's EBIT of 円-1,284.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medinet Co. Medinet Co's current EBIT is 円-1,284.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.74, compared to a current price of 円25.00 — trading 40.1% below its estimated fair value. The current EBIT is 円-1,284.3 Mil. Medinet Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current EBIT is 円-1,284.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medinet Co (TSE:2370) Overvalued in 2026?

Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued. The current stock price of 円25.00 is trading 40.1% below its estimated GF Value™ of 円41.74. GuruFocus considers Medinet Co to be Possible Value Trap.

Key valuation signals for TSE:2370:

  • EBIT: 円-1,284.3 Mil
  • GF Value™: 円41.74 vs. price of 円25.00 (40.1% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medinet Co Business Description

Address 1-1 Heiwajima 6-chome, 9th Floor, TRC Center Building, Ota-ku, Yokohama, JPN, 143-0006
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
41GF Score

Get the complete analysis for TSE:2370

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円25.00
Price
円41.74
GF Value